Stay updated with breaking news from Factor Collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension
Changes in average height in a population say a lot about how nongenetic factors can affect human development.
The Lancet reports that in patients with resistant hypertension, aprocitentan was well-tolerated and superior to placebo in lowering blood pressure at week 4 with a sustained effect at week 40Upon approval
Exploring medication adherence and its associated factors among hypertension outpatients attending a tertiary-level cardiovascular hospital in Tanzania
Antihypertensive Medication Adherence and Associated Factors: A Cross-Sectional Analysis of Patients Attending a National Referral Hospital in Asmara, Eritrea